Literature DB >> 23275086

Effect of tumor suppressor PTEN gene on apoptosis and cell cycle of human airway smooth muscle cells.

Liang Luo1, Yuan Qi Gong, Xiefei Qi, Wenyan Lai, Haibing Lan, Yaling Luo.   

Abstract

It is well established that hyperplasia and decreased apoptosis of airway smooth muscle cells (ASMCs) play an important role in the asthmatic airway remodeling. Tumor suppressor PTEN gene with phosphatase activity plays an important regulatory role in embryonic development, cell proliferation, and apoptosis, cell cycle regulation, migration (invasion) of the cytoskeleton. We hypotheses that PTEN gene could affect the growth and viability of ASMCs through the regulation of PI3K/Akt, MAPK, and cell cycle-related gene expression. We constructed a recombinant adenovirus to transfect ASMCs. Cells were divided into the overexpression of PTEN gene group (Ad-PTEN-GFP), negative control group (Ad-GFP), and blank control group (DMEM). The cell apoptosis of ASMCs were evaluated by Hoechst-33342 staining and PE-7AAD double-labeled flow cytometry. The cell cycle distribution was observed by flow cytometry with PI staining. The expression of PTEN, p-Akt, total-Akt, p-ERK1/2, total-ERK1/2, cleaved-Caspases-3, Caspases-9, p21, and Cyclin D1 were tested by the Western blotting. Our study revealed that overexpression of PTEN gene did not induce apoptosis of human ASMCs cultured in vitro. However, overexpression of PTEN inhibited proliferation of human ASMCs cultured in vitro and was associated with downregulation of Akt phosphorylation levels, while did not affect ERK1/2 phosphorylation levels. Moreover, overexpression of PTEN could induce ASMCs arrested in the G0/G1 phase through the downregulation of Cyclin D1 and upregulation of p21 expressions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23275086     DOI: 10.1007/s11010-012-1484-7

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  26 in total

1.  Airway smooth muscle as a target for asthma therapy.

Authors:  Julian Solway; Charles G Irvin
Journal:  N Engl J Med       Date:  2007-03-29       Impact factor: 91.245

Review 2.  Is airway smooth muscle the "missing link" modulating airway inflammation in asthma?

Authors:  Omar Tliba; Yassine Amrani; Reynold A Panettieri
Journal:  Chest       Date:  2008-01       Impact factor: 9.410

3.  The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene.

Authors:  J Li; L Simpson; M Takahashi; C Miliaresis; M P Myers; N Tonks; R Parsons
Journal:  Cancer Res       Date:  1998-12-15       Impact factor: 12.701

Review 4.  The functional consequences of airway remodeling in asthma.

Authors:  P D Paré; C R Roberts; T R Bai; B J Wiggs
Journal:  Monaldi Arch Chest Dis       Date:  1997-12

5.  PTEN modulates vascular endothelial growth factor-mediated signaling and angiogenic effects.

Authors:  Jianhua Huang; Christopher D Kontos
Journal:  J Biol Chem       Date:  2002-01-09       Impact factor: 5.157

6.  Retinoic acid inhibits airway smooth muscle cell migration.

Authors:  Regina M Day; Young H Lee; Ah-Mee Park; Yuichiro J Suzuki
Journal:  Am J Respir Cell Mol Biol       Date:  2006-02-02       Impact factor: 6.914

7.  Costs of asthma in the United States: 2002-2007.

Authors:  Sarah Beth L Barnett; Tursynbek A Nurmagambetov
Journal:  J Allergy Clin Immunol       Date:  2011-01       Impact factor: 10.793

8.  Upregulation of PTEN in glioma cells by cord blood mesenchymal stem cells inhibits migration via downregulation of the PI3K/Akt pathway.

Authors:  Venkata Ramesh Dasari; Kiranpreet Kaur; Kiran Kumar Velpula; Meena Gujrati; Daniel Fassett; Jeffrey D Klopfenstein; Dzung H Dinh; Jasti S Rao
Journal:  PLoS One       Date:  2010-04-26       Impact factor: 3.240

9.  PTEN induces G1 cell cycle arrest and inhibits MMP-9 expression via the regulation of NF-kappaB and AP-1 in vascular smooth muscle cells.

Authors:  Sung-Kwon Moon; Hong-Man Kim; Cheorl-Ho Kim
Journal:  Arch Biochem Biophys       Date:  2004-01-15       Impact factor: 4.013

Review 10.  Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis.

Authors:  K M Yamada; M Araki
Journal:  J Cell Sci       Date:  2001-07       Impact factor: 5.285

View more
  7 in total

1.  Hypoxia-inducible factor-1α promotes proliferation of airway smooth muscle cells through miRNA-103-mediated signaling pathway under hypoxia.

Authors:  Cantang Zhang; Jin Gao; Shuyang Zhu
Journal:  In Vitro Cell Dev Biol Anim       Date:  2021-12-10       Impact factor: 2.416

Review 2.  PTEN: An Emerging Potential Target for Therapeutic Intervention in Respiratory Diseases.

Authors:  Bangrong Cai; Liu Yang; Young Do Jung; Ying Zhang; Xinguang Liu; Peng Zhao; Jiansheng Li
Journal:  Oxid Med Cell Longev       Date:  2022-06-30       Impact factor: 7.310

Review 3.  Airway smooth muscle in airway reactivity and remodeling: what have we learned?

Authors:  Y S Prakash
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-10-18       Impact factor: 5.464

4.  Melittin restores PTEN expression by down-regulating HDAC2 in human hepatocelluar carcinoma HepG2 cells.

Authors:  Hui Zhang; Bin Zhao; Cheng Huang; Xiao-Ming Meng; Er-Bao Bian; Jun Li
Journal:  PLoS One       Date:  2014-05-02       Impact factor: 3.240

Review 5.  Crosstalk Between Signaling Pathways Involved in the Regulation of Airway Smooth Muscle Cell Hyperplasia.

Authors:  Hui Min Yap; Daud Ahmad Israf; Hanis Hazeera Harith; Chau Ling Tham; Mohd Roslan Sulaiman
Journal:  Front Pharmacol       Date:  2019-10-09       Impact factor: 5.810

6.  PTEN participates in airway remodeling of asthma by regulating CD38/Ca2+/CREB signaling.

Authors:  Yuanyuan Wu; Yiyi Lu; Fan Zou; Xinping Fan; Xudong Li; Hongni Zhang; Haijuan Chen; Xiuzhen Sun; Yun Liu
Journal:  Aging (Albany NY)       Date:  2020-08-27       Impact factor: 5.682

7.  PTEN gene silencing contributes to airway remodeling and induces airway smooth muscle cell proliferation in mice with allergic asthma.

Authors:  Xin Wen; Jing Yan; Xin-Rui Han; Gui-Hong Zheng; Ran Tang; Li-Fang Liu; Dong-Mei Wu; Jun Lu; Yuan-Lin Zheng
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 3.005

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.